VYGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Voyager Therapeutics Inc (VYGR) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has shown significant revenue growth in the latest quarter, the negative net income trend and lack of clear trading signals or positive catalysts make it less appealing for immediate investment. Additionally, technical indicators suggest a neutral to bearish trend, and there are no significant recent developments or news to drive the stock upward.
The MACD is slightly positive and expanding, suggesting mild bullish momentum. However, the RSI is neutral at 52.318, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at 3.733, and resistance is at 4.092. The stock is currently trading near its pivot point of 3.913, with no clear breakout signals.
Revenue growth of 144.28% YoY in Q4 2025, indicating potential business expansion. Gross margin remains strong at 100%.
Net income dropped by -20.47% YoY, and EPS declined by -20.34% YoY, reflecting ongoing profitability challenges. No recent news, congress trading data, or significant hedge fund/insider activity to act as a catalyst.
In Q4 2025, revenue increased significantly to $15.34M (+144.28% YoY), but net income fell to -$27.43M (-20.47% YoY), and EPS dropped to -0.47 (-20.34% YoY). Gross margin remains strong at 100%, but the company is still unprofitable.
No recent analyst rating or price target changes are available for VYGR.
